Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.

Platelet production occurs principally in the bone marrow in a process known as thrombopoiesis. During thrombopoiesis, hematopoietic progenitor cells differentiate to form platelet precursors called megakaryocytes, which terminally differentiate to release platelets from long cytoplasmic processes termed proplatelets. Megakaryocytes are rare cells confined to the bone marrow and are therefore difficult to harvest in sufficient numbers for laboratory use. Efficient production of human megakaryocytes can be achieved in vitro by culturing CD34+ cells under suitable conditions. The protocol detailed here describes isolation of CD34+ cells by magnetic cell sorting from umbilical cord blood samples. The necessary steps to produce highly pure, mature megakaryocytes under serum-free conditions are described. Details of phenotypic analysis of megakaryocyte differentiation and determination of proplatelet formation and platelet production are also provided. Effectors that influence megakaryocyte differentiation and/or proplatelet formation, such as anti-platelet antibodies or thrombopoietin mimetics, can be added to cultured cells to examine biological function.

[1]  W. Ouwehand,et al.  Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming , 2016, Nature Communications.

[2]  B. Chong,et al.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro , 2015, Haematologica.

[3]  Kwang-Soo Kim,et al.  Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[4]  P. Lev,et al.  Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count , 2014, British journal of haematology.

[5]  L. Khachigian,et al.  Drug-induced immune thrombocytopenia. , 2013, Hematology/oncology clinics of North America.

[6]  E. Hahm,et al.  Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice , 2011, Cell Research.

[7]  L. Khachigian,et al.  A monopartite sequence is essential for p45 NF‐E2 nuclear translocation, transcriptional activity and platelet production , 2010, Journal of thrombosis and haemostasis : JTH.

[8]  A. Venditti,et al.  Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management , 2007, Thrombosis and Haemostasis.

[9]  J. Hartwig,et al.  Mechanics of proplatelet elaboration , 2007, Journal of thrombosis and haemostasis : JTH.

[10]  T. Takayama,et al.  Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34+ Cells , 2006, Stem cells.

[11]  P. Martiat,et al.  Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. , 2005, Stem cells and development.

[12]  J. Reems,et al.  A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. , 2005, Blood cells, molecules & diseases.

[13]  J. Reems,et al.  Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. , 2004, Experimental hematology.

[14]  R. Lemieux,et al.  Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. , 2003, Journal of hematotherapy & stem cell research.

[15]  R. Bornstein,et al.  Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin‐induced differentiation , 2001, British journal of haematology.

[16]  M. Hokom,et al.  Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. , 1995, Blood.

[17]  R. Schreiber,et al.  In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. , 1994, Blood.

[18]  A. Nakeff,et al.  Separation of megakaryocytes from mouse bone marrow by velocity sedimentation. , 1974, Blood.

[19]  J. Reems,et al.  In vitro megakaryocyte production and platelet biogenesis: state of the art. , 2010, Transfusion medicine reviews.

[20]  N. Kotov,et al.  Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. , 2009, Experimental hematology.

[21]  W. Piacibello,et al.  In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. , 2003, Haematologica.

[22]  E. Ball,et al.  A unique population of cd34+ cells in cord blood , 1995, Stem cells.